1. Home
  2. VNDA vs TCX Comparison

VNDA vs TCX Comparison

Compare VNDA & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TCX
  • Stock Information
  • Founded
  • VNDA 2002
  • TCX 1992
  • Country
  • VNDA United States
  • TCX Canada
  • Employees
  • VNDA N/A
  • TCX N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TCX EDP Services
  • Sector
  • VNDA Health Care
  • TCX Technology
  • Exchange
  • VNDA Nasdaq
  • TCX Nasdaq
  • Market Cap
  • VNDA 237.9M
  • TCX 215.1M
  • IPO Year
  • VNDA 2006
  • TCX 1996
  • Fundamental
  • Price
  • VNDA $4.34
  • TCX $19.40
  • Analyst Decision
  • VNDA Strong Buy
  • TCX
  • Analyst Count
  • VNDA 3
  • TCX 0
  • Target Price
  • VNDA $15.33
  • TCX N/A
  • AVG Volume (30 Days)
  • VNDA 519.0K
  • TCX 20.1K
  • Earning Date
  • VNDA 05-07-2025
  • TCX 05-08-2025
  • Dividend Yield
  • VNDA N/A
  • TCX N/A
  • EPS Growth
  • VNDA N/A
  • TCX N/A
  • EPS
  • VNDA N/A
  • TCX N/A
  • Revenue
  • VNDA $201,351,000.00
  • TCX $369,427,000.00
  • Revenue This Year
  • VNDA $16.86
  • TCX N/A
  • Revenue Next Year
  • VNDA $39.78
  • TCX N/A
  • P/E Ratio
  • VNDA N/A
  • TCX N/A
  • Revenue Growth
  • VNDA 13.37
  • TCX 6.66
  • 52 Week Low
  • VNDA $3.81
  • TCX $13.27
  • 52 Week High
  • VNDA $6.75
  • TCX $26.48
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 51.79
  • TCX 63.05
  • Support Level
  • VNDA $4.17
  • TCX $18.24
  • Resistance Level
  • VNDA $4.41
  • TCX $19.95
  • Average True Range (ATR)
  • VNDA 0.16
  • TCX 0.68
  • MACD
  • VNDA 0.03
  • TCX 0.13
  • Stochastic Oscillator
  • VNDA 73.61
  • TCX 81.17

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.

Share on Social Networks: